U.S. Food and Drug Administration. Decentralized Clinical Trials for Drugs, Biological Products, and Devices Draft Guidance Webinar (20/06/2023)

FDA Announces Additional Steps to Modernize Clinical Trials (06/06/2023)

FDA Takes Additional Steps to Advance Decentralized Clinical Trials (02/05/2023)

Digitally enabled decentralised research: opportunities to improve the efficiency of clinical trials and observational studies

Decentralised clinical trials: ethical opportunities and challenges

Decentralized clinical trials (DCTs): A few ethical considerations

Conducting clinical trials over the internet: feasibility study